Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Noxxon Pharma starts dosing in Phase I/II trial of NOX-A12 for cancer

Go Top